American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 691-698 , October 2008

Etiology and Clinical Characteristics of Membranous Nephropathy in Chinese Patients

Received 18 October 2007 ,Accepted 4 June 2008.

References 

  1. Abe S, Amagasaki Y, Konishi K, et al. Idiopathic membranous glomerulonephritis: Aspects of geographical differences. J Clin Pathol. 1986;39:1193–1198
  2. Cahen R, Francois B, Trolliet P, et al. Etiology of membranous glomerulonephritis: A prospective study of 82 adult patients. Nephrol Dial Transplant. 1989;4:172–180
  3. Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol. 1986;25:122–128
  4. Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295:741–746
  5. Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–923
  6. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol. 2005;16:1195–1204
  7. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: From Heymann nephritis to alloimmunization. J Am Soc Nephrol. 2005;16:1205–1213
  8. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005;16:1214–1222
  9. Cattran D. Management of membranous nephropathy: When and what for treatment. J Am Soc Nephrol. 2005;16:1188–1194
  10. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920–929
  11. Schwartz GJ, Haycock GB, Edelmann CM, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259–263
  12. Silva FG, D'Agati VD, Nadasdy T. Renal Biopsy Interpretation. In: New York, NY: Churchill Livingstone; 1996;p. 132–142
  13. Striker G, Striker LJ, D'Agati VD. The Renal Biopsy. In: (ed 3). Philadephia, PA: Saunders; 1997;p. 60–69
  14. Churg J, Bernstein J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Diseases. In: New York, NY: Igaku Shoin; 1994;p. 67
  15. Hochberg MC. Updating the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725–1726
  16. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241–250
  17. Bjørneklett R, Vikse BE, Svarstad E, et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006;70:1510–1517
  18. Casato M, Taliani G, Pucillo LP, et al. Cryoglobulinaemia and hepatitis C virus. Lancet. 1991;337:1047–1048
  19. Disdier P, Harle JR, Weiller PJ. Cryoglobulinaemia and hepatitis C infection. Lancet. 1991;338:1151–1152
  20. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol. 1991;9:621–624
  21. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490–1495
  22. Misiani R, Bellavita P, Fnai D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992;117:573–577
  23. Levey JM, Bjornsson B, Banner B, et al. Mixed cryoglobulinemia in chronic hepatitis C infection. Medicine. 1994;73:53–67
  24. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–470
  25. Doutrelpont J-M, Adler M, Willems M, et al. Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet. 1993;341:317–318
  26. Harle JR, Disdier P, Dussol B, et al. Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet. 1993;341:904–905
  27. Rollino C, Roccatello D, Giachino O, et al. Hepatitis C virus infection and membranous glomerulonephritis. Nephron. 1991;59:319–320
  28. Davda R, Peterson J, Weiner R, et al. Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis. 1993;22:452–455
  29. Hu SL, Jaber BL. Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy. Clin Nephrol. 2005;63:41–45
  30. Uchiyama-Tanaka Y, Mori Y, Kishimoto N, et al. Membranous glomerulonephritis associated with hepatitis C virus infection: Case report and literature review. Clin Nephrol. 2004;61:144–150
  31. Lee JC, Yamauchi H, Hopper J. The association of cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41–51
  32. Brueggemeyer CD, Ramirez G. Membranous nephropathy: A concern for malignancy. Am J Kidney Dis. 1987;9:23–26
  33. Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5–10
  34. Yahata N, Kawanishi Y, Okabe S, et al. Membranous glomerulonephritis with nephrotic syndrome associated with chronic lymphocytic leukemia. Am J Nephrol. 2000;20:402–407
  35. Tourneur F, Bouvier R, Langue J, et al. Membranous nephropathy and orbital malignant tumor. Pediatr Nephrol. 2000;14:53–55
  36. Ashman N, Steele JP, Sheaff M, et al. Membranous nephropathy resolving with treatment of bronchial carcinoid tumor. Am J Kidney Dis. 2000;36:E15
  37. Lefaucheur C, Stengel B, Nochy D, et al. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006;70:1510–1517
  38. Sethi S. Membranous glomerulonephritis with monoclonal immune deposits and crescents. Nephrol Dial Transplant. 2005;20:1768–1769
  39. Gluck MC, Gallo G, Lowenstein J, et al. Membranous glomerulonephritis (Evolution of clinical and pathological features). Ann Intern Med. 1973;78:1–12

PII: S0272-6386(08)01058-5

doi: 10.1053/j.ajkd.2008.06.006

American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 691-698 , October 2008